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Highlights 
 True loss-less reversed-phase fractionation using nano-flow is feasible 
 Ability to collect fractions of 300 nL manually 
 Simple dilute-and-shoot strategy to collect and analyze concatenated fractions 
 Improved number of peptide ID’s through avoiding drying/reconstitution steps 
 Mildly acidic reversed-phase chromatography exhibits sufficient orthogonality  
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A proteomic workflow for a simple loss-less manual nano-fractionation (300 nL/fraction) for 
low µg sample amounts which avoids the need to dry down or transfer fractions to 
autosampler vials is shown to be feasible. It is demonstrated that the conventional 
procedure of drying samples down followed by reconstitution negatively affects the number 
of protein and peptide identifications.  Furthermore, these losses seem to disproportionately 
affect hydrophobic peptides from the drying down and reconstitution step. By collecting and 
concatenating the fractions while the outlet of the column is submerged in a small 
predefined volume of 0.2 % formic acid, the content of acetonitrile in the collecting vials was 
lowered such that it was compatible with direct injection for the online analysis. This 
additionally resulted in a time gain of approx. an hour for the total fractionation time. 
Acetonitrile concentrations up to 7.5 % do not seem to compromise the chromatographic 
performance in the online analysis. Using as little as 2 µg digested HeLa lysate, approx. 7000 
protein groups could be easily identified with 2 or more unique peptides. This was the case 
when fractionation was performed at pH 10 as well as at pH 5.5.   
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1. Introduction 
High-pH or basic reversed-phase (BRP) fractionation (pH > 9) has been successfully 
implemented as part of proteomic workflows for more than a decade [1-3]. Such workflows 
are carried out to maximize protein identification in complex protein samples. They 
generally consist of a fractionation step after which each fraction is dried and reconstituted. 
Each fraction is then analyzed on nano-RP LC-MS. BRP fractionation is carried out off-line by 
using spin-columns protocols (Stage tips[4]), off-line by collecting fractions from a 
chromatographic column or in an on-line fashion[5]. The use of BRP fractionation with 
chromatographic columns in the first dimension has been shown to have better 
orthogonality with low-pH (pH > 4) reversed phase (RP) separations compared to low pH RP 
or SCX separations [6, 7]. Additionally, it has been shown to outperform fractionation 
protocols using gel-based first dimension separations [8]. Although BRP x low-pH RP does 
not have the orthogonality as seen in HILIC x low-pH RP separations [3],  this difference in 
orthogonality does not need to compromise the final coverage. By using the concept of 
concatenation of the fractions, analysis time can be reduced dramatically while maintaining 
high proteomic coverage [6, 9, 10]. Analysis of concatenated fractions yields chromatograms 
with evenly distributed peptide intensities even if both separation dimensions are not 
completely orthogonal[10]. For most chromatographists, it is counter intuitive to perform 
high-pH reversed phase separations on silica-based particles. However, solutions to the 
problems associated with silica instability at high pH have been described and 
addressed[11], and nowadays there are several silica based RP materials and columns 
available which exhibit good stability (> 250 hours) at high pH values. 
One challenge associated with most of the fractionation protocols described is the relatively 
large amount of starting material needed to be able to perform experiments to unravel the 
deep proteome. To address this, efforts have been made to scale down the fractionation and 
concatenation allowing analysis of nano-gram (ng) to low micro-gram (µg) amounts of 
starting material. In recent work on nanoPOTS[12, 13] it was shown that fractionation and 
concatenation was carried out with nano-volumes eluting from the 1st dimension. Fractions 
were collected and concatenated in nanowells. After collection, the aliquots were allowed to 
dry and then reconstituted in LC buffer before analysis[13]. To our knowledge these are the 
only studies dealing with nano-flow fraction collection. A similar principle was investigated 
by Kulak et al.[14] where a nano-fractionator was introduced to handle microliter fractions 
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from a 250 µm ID capillary column. Also, here, a drying down and reconstitution step was 
necessary to make the concatenated fractions compatible with the on-line analysis. In most 
cases the drying down and reconstitution of samples seems inevitable, although it 
contributes to a peptide loss of on average 10 -15%[15, 16]. While BRP is becoming more 
common place in proteomics, there is still room for improvement to obtain the maximal 
amount of information from very small amounts of sample by optimizing the collection of 
nano-volumes and the downstream on-line analysis. 
This paper explores the possibility of manual nano-flow acidic and basic- fractionation and 
concatenation using simple means. Combined with a downstream proteomic workflow that 
does not require any transfer of sample between vials or drying down and reconstitution of 
samples, this method provides true loss-less fractionation for maximal protein identification 
of samples containing a total amount of protein in the low microgram range.  
 
 
2. Experimental section 
 
2.1 Chemicals and reagents 
Unless otherwise stated, chemicals used were of analytical grade.  PierceTM HeLa protein 
digest standard (20 µg/vial) from Thermo Scientific (Rockford, Il, USA) was used as complex 
sample. 
 
2.2 Preparation of HeLa samples containing varying amounts of Acetonitrile. 
A stock solution of 100 µg/mL HeLa was diluted with a 0.2% formic acid solution containing 
varying amounts of Acetonitrile (MeCN): 2.25 µL HeLa stock + 3.75 µL x % MeCN in 0.2 % 
formic acid where x was either 0, 4, 8, 12, 16, 20 and 24 %. This yielded after dilution 6 µL 
samples containing 37.5 µg/mL HeLa in 0, 2.5, 5, 7.5, 10, 12.5, and 15 % MeCN. 4 µL of each 
sample was injected for analysis. 
 
2.3 Fractionation conditions 
Fractionation of the samples was carried out using a Proxeon Easy-nLC II (Thermo Scientific, 
San Jose, CA, USA). No column heating was applied (the backpressure during the 
fractionation was approx. 150-170 bar). A 100 μm I.D x 25 cm column with an in-house made 
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Kasil frit and packed in-house with ReproSil-Pur C18-AQ 1.9 μm (Dr. Maisch GmbH, 
Ammerbuch, Germany) was used for separation. The flow was set to 200 nL/min. The 
gradient used was adapted from [14]. In short, the basic reversed phase fractionation mobile 
phase A consisted of 2 % MeCN in 20 mM NH4Ac pH 10, mobile phase B consisted of 80 % 
MeCN in 20 mM NH4Ac pH 10. The following gradient program was carried out: 3 - 30 % 
Solvent B (45 min), 30 - 60 % B (17 min), 60 - 95 % B (5 min), and finally constant at 95 % B 
for 3 min. After this the gradient returned to 3 % B in 10 min. Re-equilibration of the column 
(>15 column volumes) using starting conditions was performed for 30 min before injection 
of each sample. Samples were adjusted to pH 10 before injection. 
Fraction collection was initiated from the moment the gradient began. Each fraction lasted 
for 90 sec (300 nL) and was collected in a vial containing a defined volume of 0.2 % FA.  
All fractions were then pooled into a total of 8 samples according to the following 
concatenation scheme: fractions 1, 9, 17, 25, 33, and 41 were pooled; fractions 2, 10, 18, 26, 
34, and 42 were pooled; and so on to create 8 concatenated samples (1.8 μL each) consisting 
of 6 pooled fractions. 
The conditions for fractionation with the 250 µm column (250 µm I.D. x 360 µm approx. 20 
cm in length; in-house packed using the same conditions as for the 100 µm column) were as 
follows: the flow rate was set to 1 µL/min, while the gradient was the same and fractions 
were concatenated in the same manner as for the 100 µm column. The difference was that 
the fractions were collected in dry Eppendorf tubes. After pooling of the fractions, the 
pooled samples were dried by SpeedVac and reconstituted in 0.2 % formic acid.  
 
2.4 Manual fractionation 
During column equilibration, sample pick-up, and sample loading the flow from the 
fractionation column was placed in a vial marked “waste”. At the moment the gradient 
started to run (t = 0 min), the fritted side of the column was submerged in the aliquot of 0.2 
% formic acid in the first collection vial. It was placed such that there was little or no contact 
of the column with the walls of the vial. See Figure 1. 
After 90 seconds, the column was carefully transferred from the first collection vial, avoiding 
touching the walls of the vial, to be submerged in the aliquot of 0.2 % formic acid in the 
second collection vial. This continued as described above (concatenation scheme). After the 
end of the fractionation the exit of the column was placed in the vial marked “waste” again. 
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In the case that (parts of) the samples needed to be dried down, Eppendorf vials were used 
for fraction collection. If the samples could be injected directly, autosampler vials were 
chosen for fraction collection. 
 
2.5 Evaluation of the retention time performance at various pH values 
The fritted column prepared for the fractionation (see above) was coupled to a PicoTipTM 
emitter (OD 360µm, ID 20µm, Tip 10 µm) from New Objective (Woburn, MA, USA). The 
analyses were carried out on a Proxeon Easy-nLC 1000 coupled online to an Orbitrap Elite 
mass spectrometer. The gradient used was the same as for the fractionation (see above). All 
mobile phases A consisted of 2 % MeCN / 98 % aqueous component, all mobile phases B 
consisted of 80 % MeCN / 20 % aqueous component. For pH 2 the aqueous component was 
0.2 % formic acid, for pH 5.5 the aqueous component was 20 mM ammonium acetate, for 
pH 10 the aqueous component was 20 mM ammonium formate. For this evaluation, 2 µL of 
1 µg/µL HeLa standard was injected 
 
2.6 Liquid chromatography-mass spectrometry 
2.6.1 Chromatographic conditions 
Gradient elution and sample injection was performed using a Proxeon easy-nLC 1000 
(Thermo Scientific, San Jose, CA, USA). A 50 μm I.D x 25 cm column with a 10 μm 
electrospray tip (PicoFrit ™ from New Objective, Woburn, MA, USA) in-house packed with 
ReproSil-Pur C18-AQ 1.9 μm (Dr. Maisch GmbH, Ammerbuch, Germany) was used for 
separation. The flow was set to 220 nL/min. Mobile phase A consisted of 2 % MeCN in 0.2 % 
FA, mobile phase B consisted of 80 % MeCN in 0.2 % FA.  
For the 120 minute gradient the following program was carried out: 2–6% mobile phase B 
(7.5 min), 6-25% B (82.5 min), 25-40% B (30 min) and to 100% B (1 min). The flow of 100% B 
was then kept constant for 15 min.  
For the 60 minute gradient the following program was carried out: 2–6% mobile phase B 
(3.75 min), 6-25% B (41.25 min), 25-40% B (15 min) and to 100% B (0.5 min). The flow of 
100% B was then kept constant for 7.5 min.  
In both cases, re-equilibration of the column (>15 column volumes) using starting conditions 
was performed for 30 min before injection of the next sample.  
2.6.2 Mass spectrometric conditions 
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Mass spectrometric detection was carried out either on an Orbitrap Fusion mass 
spectrometer or an Orbitrap Elite mass spectrometer (both Thermo Scientific, San Jose, CA, 
USA) operating in DDA mode.  
Settings for the Orbitrap Fusion: Xcalibur version 4.1.50 and Orbitrap Fusion Tune 
application version 3.0.2041 were used to generate instrumental methods as well as to 
operate the mass spectrometer. A generic MS OT/ddMS2 IT HCD method was used as 
follows: The MS1 was operated in profile mode with a resolution of 120000 and a scan range 
between 350 and 1500 m/z. The maximum ion injection time was 50 ms with an AGC target 
of 4e5. MS/MS was carried out in the ion trap operated in centroid mode, with a maximum 
injection time of 35 ms and an AGC target of 1e4. The isolation width was 1.6 m/z and the 
collision energy was 35 %. Dynamic exclusion was set to 60 sec and the overall cycle time 
was 3 sec. 
Settings for the Orbitrap Elite: Xcalibur version 2.2.SP1.48 and Thermo Tune Plus application 
version 2.7.0.1103 SP1 were used to generate instrumental methods as well as to operate 
the mass spectrometer. A generic MS OT/ddMS2 IT CID method was used as follows: The 
MS1 was operated in profile mode with a resolution of 120000 and a scan range between 
400 and 1600 m/z. MS/MS was carried out in the ion trap operated in centroid mode. The 
isolation width was 2.0 m/z, the collision energy was 35 %, and the activation time was 10 
ms. Dynamic exclusion was set to 90 sec. 
 
2.7 Data analysis 
Raw data were analyzed with MaxQuant (version 1.6.1.0)[17, 18] against a Human database 
(downloaded from UniProt on July 19th 2017, containing 93 591 sequences) and a 
contaminant database (245 entries). A decoy database was constructed by MaxQuant on-
the-fly to determine the false discovery rate (FDR). Trypsin ([KR][^P]) was specified as the 
proteolytic enzyme with up to two missed cleavages. Carboxyamidomethyl modification of 
cysteine (57.0215 Da) was specified as a fixed modification. Variable modifications included 
oxidation of methionine (15.9949 Da) and protein N-terminal acetylation (42.0106 Da). 
Precursor mass tolerance was 4.5 ppm after recalibration in MaxQuant while fragment mass 
tolerance was 0.5 Da. Scores were thresholded to achieve a peptide and protein FDR of 1%. 
 
3 Results and discussion 
         
 8 
 
3.1 The effect of fractionation on peptide ID using small volumes and drying down 
fractions 
In most fractionation workflows the separation is performed with capillary or micro flow, 
which due to the larger volume necessitates drying down the fractions by SpeedVac and 
subsequently reconstituting samples with a solvent compatible with the analysis in the 
second dimension (which typically is performed using nano-flow). Drying down the sample 
leads to loss of peptides [15] and potentially to loss of information. In the following section 
both the effect of drying down and fractionation on the type of peptides identified is 
investigated and discussed.  
 
3.1.1 Comparison of single HeLa analysis (not dried) with the analysis of dried and 
reconstituted fractionated HeLa sample.  
Comparing the number of peptides identified in a single-shot injection of whole HeLa digest 
to that identified from the non-contiguously fractionated/concatenated samples shows that 
the majority of peptides were identified in the fractionated/concatenated sample (Fig 2a). 
This was expected since the fractionation/concatenation reduces the sample complexity and 
increases the peak capacity as well as utilizes substantially increased instrument time. 
Additionally, it shows that most of the peptides identified in the single HeLa injection were 
also identified in the fractionated/concatenated sample. However, more than 6000 peptides 
were only identified in the single injection, representing about 16% of the total peptides 
identified from the non-fractionated sample. This was surprising since the same HeLa sample 
was used for both the fractionation and the single injection, and we expected that nearly all 
the peptides identified in the single injection should also have been identified in the 
fractionated/concatenated samples. We therefore analyzed the properties of the peptides 
that were identified in solely the single-shot analysis versus those only identified in the 
fractionated/concatenated samples and those identified in both analyses and discovered a 
trend in which the peptides that were only identified in the single-shot analysis were 
primarily eluting very late in the online gradient (Fig. 2b). This suggested that the 
fractionation/concatenation procedure, which required drying down the samples in plastic 
microcentrifuge tubes and reconstituting in 0.2% FA prior to online LC-MS analysis, was 
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primarily resulting in loss of the most hydrophobic peptides compared to the single-shot 
analysis.  
 
3.1.2 Comparison of single HeLa analysis (not dried) with the single HeLa analysis which is 
dried down. 
We therefore analyzed whether a similar effect of drying down on the nature and number of 
identified peptides is seen with a HeLa standard which was dried down/reconstituted prior 
to the online LC-MS injection compared to a HeLa standard which was not dried down but 
injected directly.  As expected, we observed a clear trend in which the highest percentage of 
the peptides only identified in the sample that was not dried down were present in the final 
portion (last 30 minutes of a total 120 minutes) of the online gradient (Fig. 3). These results 
support the notion that -hydrophobic peptides are preferentially lost during the 
lyophilization and reconstitution procedure, likely because very hydrophobic peptides 
remain stuck to the plastic walls of the microcentrifuge tubes and are extremely difficult to 
re-solubilize. 
 
3.1.3 Comparison of a dried down and reconstituted fractionated HeLa sample with a diluted 
(non-dried down) fractionated HeLa sample. 
To further assess the impact of drying samples down and reconstituting after 
fractionation/concatenation, a final comparison was performed between identical fractions 
which were either collected in 0.2 % formic acid, dried down and reconstituted before LC-MS 
analysis or just collected directly in 0.2 % formic acid before injection for LC-MS. A basic 
reversed phase fractionation and concatenation of a HeLa sample was carried out and the 
fractions were collected in microcentrifuge tubes containing 8.4 µL 0.2 % formic acid. After 
concatenation of 48 fractions, each of the 8 Eppendorf vials contained 10.2 µL. The content 
of each Eppendorf vial was mixed and split into two equal volumes, one volume to be dried 
down and reconstituted before injection while the other volume was injected directly.  
The results for this comparison in Figure 4 show the same trend as in Figures 2 and 3: the 
share of hydrophobic peptides is relatively higher in the samples which were collected in 
0.2% formic acid and injected directly compared to those which were dried down and 
reconstituted before injection. Moreover, 6273 more total peptides (approx. 10% more) 
were identified in the aliquots that were not dried down and reconstituted.  
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Figure 5 shows the impact of fractionation and the effect of drying down on the number of 
protein IDs and the sequence coverage. The increase in proteome coverage achieved with 
fractionation is highly significant (p⋘0.01), while the negative effect of drying down on the 
number of protein ID’s is smaller, but still significant (p<0.01). In single-shot injections of 
HeLa digest an average of 3231 protein groups (n=3) were identified, while in the dried and 
reconstituted fractions an average of 6324 proteins (n=2) were identified compared to the 
direct injection fractions where an average of 6640 proteins (n=2) were identified (in all 
cases two or more counting only proteins with  unique peptide sequences were required ).  
At the peptide level, the impact of fractionation on the number of peptide ID’s is highly 
significant (p⋘0.01), and while the impact of drying down on the number of peptides ID’s is 
smaller, it is still significant (p<0.01): in single injections an average of 21518 peptides (n=3) 
were identified, while in the dried and reconstituted fractions an average of 60261 peptides 
(n=2) were identified and in the direct injected fractions an average of 69914 peptides (n=2) 
were identified. For the sequence coverage the results were comparable: fractionation 
provided a highly significant increase in the sequence coverage (p⋘0.01), whereas the 
effect of drying down is less substantial, but still significant (p<0.05). The median protein 
sequence coverage for single injections was 13.2% (n=3), for the dried down fractions it was 
18.6% (n=2), and for the diluted fractions it was 20.9% (n=2).  
 
Altogether these results show that there is, as expected, a tremendous information gain by 
performing fractionation compared to performing a single online injection using nanoflow. 
Moreover, it is clear that drying down and reconstituting samples prior to online LC-MS 
analysis has a smaller but significant negative impact on the number of peptide 
identifications, which is especially pronounced for highly hydrophobic peptides. In the 
following sections, the concept of sample dilution ahead of sample dry down and 
reconstitution is investigated.  
 
3.2 Elimination of drying down and the consequences of sample dilution. 
From both the single-shot and fractionated analyses, we observe a disproportionate loss of 
hydrophobic peptides during the drying down/reconstitution process. Although there seems 
to be little or no effect of the drying down and reconstitution on the number of 
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identifications at the protein level, this is only because it is unlikely that the only peptides 
identified for a given protein are all very hydrophobic. Avoiding the drying down step not 
only allows for more peptide identifications and higher sequence coverage, it also makes the 
workflow less complex. We suggest to do this as follows: as the volume per fraction exiting 
the 100 µm column is extremely low, dilution is carried out instead of drying down and 
reconstituting each fraction to change both the pH and the concentration of MeCN. In order 
to collect a volume of 300 nL (volume per fraction), the end of the column is submerged into 
an aliquot of 0.2 % FA within a small microcentrifuge tube or autosampler vial. In this way 
the small droplet from the end of the column/capillary easily disperses into the much larger 
volume of FA already present in the vial. This diluted sample will not be dried down but can 
be injected directly (almost in its entirety) into the second dimension (online reversed-
phase). To accomplish this, the amount of MeCN should be sufficiently low such that band 
broadening or peptide loss during the injection phase does not occur. Table 1 column 2 
shows the percentage of MeCN present after 48 fractions of 90 sec are concatenated into 8 
vials with the gradient described above. The presence of the 0.2 % FA during the collection 
of the fraction therefore allows for sufficient dilution of the MeCN content. In the case 
presented in Table 1, collection of 48 fractions (300 nL each) into 8 concatenated samples 
leads to pooled fraction volumes of 1.8 µL. When collected in aliquots of 8.2 µL 0.2 % formic 
acid, this results in final MeCN concentrations of less than 6 % in each sample to be injected 
in the second dimension (column 3). A direct consequence of diluting the fractions instead of 
drying down/reconstitution is time gain of an hour: the time between fractionation start and 
injection of the fractions in the second dimension is for the drying down/reconstitution work 
flow (for 48 fractions) approximately 180 minutes (approx. 50 minutes column equilibration, 
72 minutes fractionation, 60 minutes for drying and reconstitution). For the dilution work 
flow this is approx. 120 minutes.  
 
3.2.1 The effect of increasing the amount of MeCN in the sample on the chromatography 
(visual evaluation) and the peak intensity of the peptides. 
To investigate this, HeLa samples with varying amounts of MeCN between 0 and 15 % were 
injected directly for LC-MS analysis with a relatively short gradient (60 minutes). The order of 
injection was from the highest MeCN concentration to the lowest. Figure 6 shows typical 
chromatograms of these injections, which demonstrate a clear effect of the MeCN 
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concentration on sample. For at least retention and separation. Especially the highest MeCN 
concentrations (12.5 and 15 % MeCN samples), large portions of the chromatogram are 
affected. However, with only the most hydrophobic peptides having their retention and 
separation properties largely unaffected. On the other hand, having between 0 - 7.5 % 
MeCN in the injected sample had minimal to no effect on all but the most hydrophilic 
peptides, whereas 10 % MeCN had more pronounced effects early in the gradient but left 
the later portion of the gradient unaffected.  
 
To better visualize the effect of MeCN present in the injected samples on peptide retention, 
we plotted the ratio of the peptide intensity at x % MeCN / peptide intensity at 0 % MeCN at 
retention times across the entire gradient (see Figure 7). In this plot, an intensity ratio of 1.0 
indicates that the peptide intensity with the given MeCN concentration (x % MeCN) was 
identical to that observed in the sample without MeCN (0 % MeCN). This analysis further 
demonstrates a strong, negative effect on the normalized peptide intensities in the 12.5 % 
MeCN samples, which is most pronounced for peptides eluting earlier than 40 or 50 minutes 
in the 12.5 or 15 % MeCN samples, respectively. On the other hand, there does not appear 
to be any significant detrimental effect on peptide intensity in samples containing 10 % 
MeCN or less at any retention time, while there may actually be a slight benefit to more 
hydrophilic peptides eluting before 40 minutes when 5 % MeCN is present in the injected 
sample. Altogether, these results suggest that having up to 10% MeCN in the sample does 
not have a significant effect on peptide chromatographic behavior. Given that we identified 
more peptides when a sample is not dried down and resuspended confirms that sample 
dilution is favorable over drying down and reconstituting, so long as the MeCN 
concentration present in the sample is less than 10 %. This is especially favorable because it 
allows for fraction collection directly into LC-MS sample vials, thus avoiding loss of sample 
during sample transfer in addition to losses from drying down and reconstitution. 
 
3.3 Evaluation of chromatographic performance in the nano-fractionation 
Obtaining sharp and narrow peaks in the first separation dimension is considered to be 
advantageous since peak splitting during the fractionation caused by broad peaks will lead to 
lower peak intensities and more complex spectra of the fractions in the on-line analysis as 
more peptides will be spread across at least two consecutive fractions. To prevent 
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overloading the column, which can be a major factor in the production of broad 
chromatographic peaks, we have not exceeded a total injection amount of 5 µg digested 
peptides on our in-house packed fractionation nano-columns. Although it is impossible to 
entirely avoid some peaks splitting into two fractions, the number of peaks eluting in three 
or more fractions should be minimal.  
Figure 8 shows a distribution for how many peptides were identified by MS/MS in a single 
collected fraction or in multiple fractions. As expected for good chromatographic 
performance, the majority of peptides (> 80%) were identified in a single fraction by MS/MS, 
whereas approximately 12% were found in 2 fractions and only 4% of peptides were 
observed in 3 or more fractions. This data indicates that there is minimal peptide signal loss 
due to peak splitting during the nano-fractionation.  
 
3.4 Evaluation of nano-fractionation at pH 10 and pH 5.5 
In addition to the conventional basic (pH 10) reversed-phase fractionation, pH 5.5 was also 
tested for off-line reversed-phase nano-fractionation. The advantage of using pH 5.5 
compared to pH 10 is the prolonged life-time of the fractionation column as well as the 
compatibility of this mid-pH with the fused silica lining sometimes used in the tubing of 
nano-HPLC pumps. Typically it is necessary to immediately replace the pH 10 mobile phases 
of the BRF fractionation system and flush the entire system and column with a low-pH buffer 
after sample fractionation is completed each day, as the basic pH 10 is corrosive to silica and 
may decrease the lifetime of system components as well as the column itself.  
Another potential advantage of fractionation at pH 5.5 is that peaks tend to be narrower at 
this pH compared to pH 10. The median peak width at pH 2 is 23.6 sec, at pH 5.5 this is 28.1 
sec and at pH 10 the peak width is 34.3 sec. Narrower peaks should cause less peak splitting 
during fractionation, which in turn would improve peptide identifications as peak intensities 
are higher for peptides eluting in single fractions compared to those eluting in two or more 
fractions. Less peak splitting would also allow for collection of more cycles at pH 5.5 (and 
thus more fractions) within a given fractionation window, thus compensating for any lower 
orthogonality of fractionation at pH 5.5 compared to that at pH 10.  
 
3.4.1 Direct on-line analysis of a tryptic HeLa digest at pH 2, 5.5, and 10 
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In order to evaluate the orthogonality of pH 5.5 and pH 10 (fractionation pH) with the typical 
on-line pH 2, the column used for fractionation was used for direct on-line analysis of 200 ng 
digested HeLa lysate. Figure 9 shows retention times of the peptides for analyses carried out 
at pH 2, pH 5.5, and pH 10 plotted against their retention times at pH 2. Also shown are 
representative on-line chromatograms for each pH. All on-line analyses were carried out in 
positive mode. A correlation of 1 or close to 1 is defined as no or little orthogonality. The 
lower the correlation the more orthogonal the retention mechanisms are. 
As expected, the correlation between multiple runs carried out at pH 2 (Fig. 9a) was close to 
1. The correlation between pH 5.5 and pH 2 was approx. 0.91 (Fig. 9b), while the correlation 
between pH 10 and pH 2 was approx. 0.71 (Fig. 9c). The on-line chromatographic profiles at 
pH 5.5 and pH 10 both look satisfactory, with sharp peaks and a rather even distribution of 
peptides throughout the chromatogram. We did not make a comparison of peak intensities 
between these pH values, as the ionizability of the peptides will vary depending on the pH. 
 
3.4.2 Nano-fractionation at pH 5.5 and on-line analysis at pH 2 
To evaluate the true utility of performing nano-fractionation at pH 5.5 instead of pH 10, we 
completed an entire LC-MS analysis of concatenated fractions derived from pH 5.5 nano-
fractionation of tryptic HeLa digest. Interestingly, despite its lower orthogonality, the 
number of protein groups (2 or more unique peptide sequences per protein) identified when 
nano-fractionation was performed at pH 5.5 with 2 µg injected (6,741 protein groups) was 
essentially the same as we achieved with fractionation at pH 10 with 2 µg injected (6,620 
protein groups). Furthermore, the total number of peptides identified at pH 5.5 was even 
slightly higher than achieved with pH 10: 74,847 vs 69,607 respectively. Injecting 4 µg for 
fractionation at pH 5.5 resulted in 7,177 identified protein groups (2 or more unique 
peptides per protein) and 86,594 peptide identifications. Therefore, we conclude that 
fractionation at pH 5.5 is a viable alternative to conventional basic reversed-phase 
fractionation at pH 10, which has the added benefit of increased lifetime and stability of the 
column and HPLC system when silica tubing is used.  
 
3.5 Study limitations and considerations 
It should be noted that this study did not investigate different fractionation schemes or the 
effect of fractionating different amounts or sources of starting material. It is possible that 
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varying the fractionation timing and/or the concatenation scheme might contribute to an 
improved number of identifications. Moreover, fractionating higher amounts of digested 
HeLa lysate would likely improve the number of identifications, although how much 
improvement could be achieved and at what amount of starting material would the system 
reach diminishing returns remains to be seen. Other studies have reported identifying up to 
11,500 different proteins in HeLa lysates, albeit with a much higher amount of starting 
material than used in the current study [14]. Additionally, here we have only investigated 
C18 reversed-phase beads as the matrix for fractionation, but this could easily be replaced 
by alternative materials like graphene or HILIC to achieve comparable or even improved 
performance.  
Setback of fractionation as described above is the manual skills needed to perform it. Since 
the exit of the column is transferred from one vial to another, there might be a chance of 
transferring peptides (on the outside of the column) to a next fraction. However, it will 
probably not affect the number of peptide and protein identifications. Cross contamination 
between injected samples will not occur as the exit of the column is washed between each 
fractionation. 
Despite this, the primary goal and novelty of this study was achieved, which was to show 
that with relatively simple means, real loss-less nano-fractionation especially of very small 
amounts of starting material (2-4 μg) can be carried out while eliminating steps such as 
sample transfer and the drying down and reconstitution of fractions that typically result in 
significant peptide losses.  
 
4. Conclusion 
The current study has shown that basic reversed-phase nano-fractionation at a low flow rate 
(200 nL/min) by means of manual collection of volumes as low as 300 nL per fraction can 
achieve high numbers of identified proteins and peptides in complex digested HeLa lysates. 
This is possible through use of partially pre-filled HPLC sample vials in which the end of the 
fractionation column is submerged in a small volume of 0.2% FA. Additionally, we found that 
drying down and reconstituting the concatenated fractions leads to significant peptide loss, 
especially of the most hydrophobic peptides. This can be circumvented by a simple dilution 
of the concatenated fractions to adjust the concentration of MeCN to values compatible 
with the on-line analysis. Dilutions of the MeCN content to 7.5% or lower do not affect the 
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chromatographic behavior or the peptide intensities. Furthermore, this does not have much 
impact on the number of protein identifications but actually increased the number of 
identified peptides by around 10%, resulting in a slight increase in the average protein 
sequence coverage. This shows that the dilution strategy is as least as good as the drying 
down / reconstitution procedure while contributing to a simpler workflow and less sources 
of error because of its true loss-less nature. In addition to basic reversed-phase nano-
fractionation, we found that mildly acidic reversed-phase nano-fractionation seems to be a 
viable alternative with the advantage that fractionation at pH 5.5 is more compatible with all 
the silica-based components in the workflow.  
 
In order to further investigate the real potential of reversed-phase nano-fractionation, 
however, optimization of the fractionation and concatenation schemes should be carried 
out. It is expected that automation of the fractionation, eliminating factors like human error 
and carry over, will improve the results presented in this study even further. All in all, true 
loss-less nano-fractionation is a valuable tool to investigate the deep proteomes of samples 
that are only available in ultra-low amounts and should find utility for a number of 
proteomics studies.  
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 Figure captions 
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Figure 1: Fraction collection can be carried out in an Eppendorf vial (A) where after the 
sample is dried down and reconstituted before it is transferred to an autosampler vial for 
analysis. Alternatively, collection can be carried out in the autosampler vial directly (B) 
without the need to transfer, dry down, or reconstitute samples, thus reducing sample loss. 
 
Figure 2: A) Venn-diagram showing the number of identified peptides in the 
fractionated/concatenated/dried/reconstituted samples (orange) and the single injected HeLa 
(blue). B) The plot shows the percentage of peptides per 10 minutes analysis time.  
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Figure 3:  A Venn-diagram showing the number of identified peptides in the dried and 
reconstituted single HeLa injections (orange, accumulated n=3) and the non-dried single 
HeLa injections (blue, accumulated n=3). The plot shows the percentage of peptides present 
in all three replicates per 10 minutes analysis time. 
 
Figure 4:  A Venn-diagram of the number of identified peptides in the dried and reconstituted 
samples (orange, 48 fractions concatenated in 8 vials) and the non-dried directly-injected 
samples (blue, 48 fractions concatenated in 8 vials). The plot shows the percentage of 
peptides per 10 minutes analysis time.  
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Figure 5: Box and Whisker plots of the protein sequence coverage achieved by fractionation 
with or without drying down/reconstituting and by single injections of HeLa digests. The cross 
marks the median. Number of protein ID’s (with 2 or more unique peptides) are shown above 
each plot. 
 
Figure 6: Base peak chromatograms of HeLa samples (37.5 µg/mL) containing 0, 5, 7.5, 10, 
12.5, and 15 % MeCN (4 µL injected), all shown with a fixed scale at an intensity of 2.50E8.  
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Figure 7: Moving average (averaged over 50 points) of peptide intensities at 5, 7.5, 10, 12.5, 
and 15 % MeCN normalized against the peptide intensities at 0 % MeCN, plotted as a 
function of retention time. The plot shows data of 1000 randomly chosen peptides. 
Chromatography was carried out using the 60 min gradient. 
 
Figure 8: The percentage of identified peptides present in only a single fraction, in two 
fractions, and so on up to all 8 fractions. The error bars are +/- absolute standard deviation 
(n=3, fractionation carried out at pH 10). 
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Figure 9: The peptide retention times from on-line runs at various pH levels plotted against 
their retention times at pH 2. a) pH 2 vs pH 2; b) pH 5.5 vs pH 2; c) pH 10 vs pH 2. Below 
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Table 1: Calculated concentration of MeCN in a non-diluted pooled fraction (maximum) and 
after 5.55x dilution (dilution to 10 µL). The calculation is carried out for 48 fractions, 90 sec 
per fraction, and assumes that the amount of MeCN at the end of the column is the same as 
can be calculated from the gradient. 
 
 
Concatenated fraction nr. MeCN  
(maximum) 
MeCN  
(after dilution to 10 µL) 
1 (pooled fractions 1, 9, 17, 25, 33, 41) 21.7 %  3.9 % 
2 (pooled fractions 2, 10, 18, 26, 34, 42) 22.1 % 4.0 % 
3 (pooled fractions 3, 11, 19, 27, 35, 43) 25.6 %   4.6 % 
4 (pooled fractions 4, 12, 20, 28, 36, 44) 27.8 %   5.0 % 
5 (pooled fractions 5, 13, 21, 29, 37, 45) 29.8 %  5.4 % 
6 (pooled fractions 6, 14, 22, 30, 38, 46) 30.6 %  5.5 % 
7 (pooled fractions 7, 15, 23, 31, 39, 47) 25.7 %  4.6 % 
8 (pooled fractions 8, 16, 24, 32, 40, 48) 20.6 % 3.7 % 
 
 
         
